CDT Equity Inc. (CDT): Total Assets
$5.65M
As of 2025-12-31
$126.71M
As of 2026-06-30
n/m
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.65M | +34.7% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $4.19M | -42.0% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $7.22M | n/a | 2025-03-28, Balance as of period end |
| 2023-06-30 | $900.0K | n/a | 2024-04-16, Balance as of period end |
| 2023-03-31 | $506.0K | n/a | 2024-04-16, Balance as of period end |
| 2022-12-31 | $5.0K | -97.7% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $213.1K | n/a | 2023-03-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| CDT Equity Inc. (CDT) | 2025-12-31 | $5.65M | +34.7% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $5.56M | -10.3% |
| AEON Biopharma, Inc. (AEON) | 2025-12-31 | $5.56M | +77.0% |
| Ernexa Therapeutics Inc. (ERNA) | 2025-12-31 | $5.83M | +10.7% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $5.37M | -6.8% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $5.33M | -60.5% |
| Polaryx Therapeutics, Inc. (PLYX) | 2025-12-31 | $5.17M | +3.4% |
| Greenwich LifeSciences, Inc. (GLSI) | 2025-12-31 | $6.18M | +50.9% |
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | $5.16M | -51.4% |
Compare CDT, JUNS, AEON, ERNA side by side · Screen every company in Pharmaceutical Preparations ↗